Physician profile
Amber O'Connor
NPI 1023646114
$9,374.01
in general payments reported to CMS, 2019-2025
14 companies · $6,210 in 2025
The $6,210 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,063 · 2024: $1,101 · 2025: $6,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,648 · Travel and Lodging: $3,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,648.25 |
| Travel and Lodging | $3,725.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,704.64 | 2023-2025 | Citrefix, Prostep, Variax |
| Treace Medical Concepts, INC. | $3,341.62 | 2025 | |
| Arthrex, INC. | $1,636.20 | 2023 | |
| Biotissue Holdings INC. | $146.68 | 2025 | |
| Paragon 28, INC. | $110.00 | 2025 | Portfolio |
| Empire Medical, INC | $104.11 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $96.46 | 2025 | |
| Averitas Pharma INC. | $95.46 | 2023-2024 | Qutenza |
| Access Pro Medical, LLC | $32.99 | 2025 | Matriderm |
| Linvatec Corporation | $25.19 | 2025 | Biobrace 23mm, Allograft Tissue, 5ms |
| Mimedx Group, INC. | $24.28 | 2025 | |
| Bioventus LLC | $21.52 | 2024 | Exogen Ultrasound Bone Healing System |
| La Jolla Pharmaceutical Company | $19.56 | 2023 | Xerava |
| Viiv Healthcare Company | $15.30 | 2024 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber O'Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.